SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Affymax, Inc. Sets Terms For 3.5 Million Share IPO

December 1, 2006 | 
1 min read
WASHINGTON, Nov 30 (Reuters) - Biopharmaceutical company Affymax Inc. filed with the U.S. Securities and Exchange Commission on Thursday to sell up to 3.5 million shares for between $22 and $24 per share in an initial public offering of stock.

>>> Discuss This Story

IPO
MORE ON THIS TOPIC
3D Paper Cut Pair of Lung dotted with yellow tumor bacteria infection spread across on a blue background with no text. Yellow dots as virus infection in the lungs. Vector Illustration.
Business
Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail
July 27, 2026
 · 
3 min read
 · 
Gabrielle Masson
Big fish eats small, takeover of the company. Art collage.
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
July 27, 2026
 · 
2 min read
 · 
Tristan Manalac
A two old parchment scrolls with a quill in a inkwell on a white background
IPO
Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotech
July 24, 2026
 · 
3 min read
 · 
Tristan Manalac
Psychedelic drug or psychedelics hallucinogenic drugs and hallucinogens representing states of consciousness and psychology or psychological hallucinating by taking mind altering substances in a 3D illustration style.
Psychedelics
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
July 24, 2026
 · 
3 min read
 · 
Gabrielle Masson